Inducing patent infringement in Hatch-Waxman ANDA litigation

被引：0

|

作者：

Main, Denise

机构：

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2012年 / 244卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

18-CHAL

引用

收藏

页数：1

相关论文

共 50 条

[11] HATCH-WAXMAN DEVELOPMENTS IN 1988
SAFIR, PO
FOOD AND DRUG LAW JOURNAL, 1989, 44 (04): : 359 - 367
[12] Hatch-Waxman and the orange book
MacAlpine, Jill
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
[13] Hatch-Waxman changes debated
Ken Chahine
Nature Biotechnology, 2000, 18 : 710 - 711
[14] CHAL 12 - FTC scrutiny of patent settlements in Hatch-Waxman cases
McKithen, Marc
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237 : 953 - 953
[15] HATCH-WAXMAN'S RENEGADES
Thomas, John R.
UNIVERSITY OF ILLINOIS LAW REVIEW, 2023, (03): : 831 - 879
[16] Hatch-Waxman changes debated
Chahine, K
NATURE BIOTECHNOLOGY, 2000, 18 (07) : 710 - 711
[17] Old drugs, new uses: Solving a Hatch-Waxman patent predicament
McPhie, DC
FOOD AND DRUG LAW JOURNAL, 2004, 59 (01) : 155 - 168
[18] Branded Drug Companies Are Successfully Asserting the Doctrine of Equivalents in Hatch-Waxman Litigation
Holman, Christopher M.
BIOTECHNOLOGY LAW REPORT, 2021, 40 (02) : 72 - 94
[19] Insurance Coverage and Induced Infringement: A Threat to Hatch-Waxman's Skinny Labeling Pathway?
Lorey, Maya
UNIVERSITY OF CHICAGO LAW REVIEW, 2023, 90 (05): : 1517 - 1563
[20] Hatch-Waxman 101: A practical guide on the regulatory impact of exclusivity, patents, and patent litigation on generic drug development and approval
Toufanian, Maryll
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251

← 1 2 3 4 5 →